2894.800CLP
5.03 TCLP
35.37 TCLP
1.72 B
About ABBOTT LABORATORIES
Sector
Industry
CEO
Robert B. Ford
Website
Headquarters
Abbott Park
Employees (FY)
114 K
Founded
1888
ISIN
US0028241000
FIGI
BBG00YFSB0Q6
Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products. It operates through the following business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.
ABBOT COVID TRIANGLE BREAKOUTABBOT has been a really bad boy but it eventually put itself in some kind of triangle.
Will it break out? I think so.
PRICE TARGET 103$
STOP LOSS: There is no stop loss!
Abbott TrendsAfter showing a bull trend that lasted several years the stock has moved to bearish teritorry in the past year. During this time the stock price has been range bound between 36 and 46. It is showing resistance at 36 levels. The relative strength of the stock when compared to the S&P 500 is indicatin
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Curated watchlists where ABTCL is featured.
Frequently Asked Questions
The current price of ABTCL is 108200.00 CLP — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BCS exchange ABBOTT LABORATORIES stocks are traded under the ticker ABTCL.
ABBOTT LABORATORIES is going to release the next earnings report on Apr 17, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for ABBOTT LABORATORIES has a max estimate of 133270.30 CLP and a min estimate of 101134.20 CLP.
ABTCL earnings for the last quarter are 1.02 K CLP whereas the estimation was 984.56 CLP which accounts for 3.57% surprise. Estimated earnings for the next quarter are 1.05 K CLP. See more details about ABBOTT LABORATORIES earnings.
ABBOTT LABORATORIES revenue for the last quarter amounts to 9.07 T CLP despite the estimated figure of 8.80 T CLP. In the next quarter revenue is expected to reach 8.98 T CLP.
Yes, you can track ABBOTT LABORATORIES financials in yearly and quarterly reports right on TradingView.
Like other stocks, ABTCL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ABBOTT LABORATORIES stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 16, 2024, the company has 114.00 K employees. See our rating of the largest employees — is ABBOTT LABORATORIES on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ABBOTT LABORATORIES EBITDA is 8.55 T CLP, and current EBITDA margin is 24.13%. See more stats in ABBOTT LABORATORIES financial statements.